Doxazosin 2mg tablets

Țară: Regatul Unit

Limbă: engleză

Sursă: MHRA (Medicines & Healthcare Products Regulatory Agency)

Ingredient activ:

Doxazosin mesilate

Disponibil de la:

Sandoz Ltd

Codul ATC:

C02CA04

INN (nume internaţional):

Doxazosin mesilate

Dozare:

2mg

Forma farmaceutică:

Oral tablet

Calea de administrare:

Oral

Clasă:

No Controlled Drug Status

Tip de prescriptie medicala:

Valid as a prescribable product

Rezumat produs:

BNF: 02050400

Prospect

680
Artwork No.
Customer
Description
Market
Language
Size
Min. Font Size
Page No.
Version No.
Date
Software
180719/2
Ennogen
Doxazosin Leaflet
UK
English
130 x 480 mm
9 pt
1 of 1
1
18-07-19
Coreldraw 12
Packaging Development
Quality Assurance (QA)
Quality Control (QC)
Production
e-mail : [e-mail]
Ph : [phone]
Colours Used
Black
Keyline
Doxazosin 1mg, 2mg, 4mg and 8mg Tablets
(doxazosin mesilate)
PACKAGE LEAFLET: INFORMATION FOR THE USER
!
If you have any further questions, ask your
doctor, pharmacist or nurse.
2.
What you need to know before you take
Doxazosin Tablets
It is used to treat:
2. WHAT YOU NEED TO KNOW BEFORE YOU
TAKE DOXAZOSIN TABLETS
!
Symptoms caused by the enlargement of the
prostate gland in men.
4.
Possible side effects
If you are undergoing eye surgery because of
cataracts (cloudiness of the lens) please inform your
eye specialist before the operation that you are using
or have previously used Doxazosin Tablets. This is
because doxazosin may cause complications during
the surgery which can be managed if your specialist is
prepared in advance.
Before starting treatment with Doxazosin Tablets your
doctor may perform tests to rule out other conditions
such as prostate cancer that may cause the same
symptoms as benign prostatic hyperplasia
(enlargement of the prostate gland).
Persistent painful erections may occur very rarely. If
this happens you should contact a doctor
immediately.
6.
Contents of the pack and other information
!
If you get any side effects, talk to your doctor,
pharmacist or nurse. This includes any possible
side effects not listed in this leaflet. See section
4.
!
Keep this leaflet. You may need to read it again.
!
This medicine has been prescribed for you only.
Do not pass it on to others. It may harm them,
even if their signs of illness are the same as
yours.
WHAT IS IN THIS LEAFLET
1.
What Doxazosin Tablets are and what they are
used for
5.
How to store Doxazosin Tablets
!
High blood pressure
In patients taking this medicine to treat high blood
pressure (hyp

Caracteristicilor produsului

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Doxazosin 2 mg Tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 2.425 mg doxazosin mesilate equivalent to 2 mg of
doxazosin.
For the full list of excipients, see 6.1.
3.
PHARMACEUTICAL FORM
Tablet
2 mg: white oblong scored tablet, “D2” engraved on one side
The score line is only to facilitate breaking for ease of swallowing
and not to divide
into equal doses.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Essential hypertension.
Symptomatic treatment of benign prostatic hyperplasia (BPH).
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
The duration of therapy will be decided by the physician.
HYPERTENSION:
The usual dosage limits of doxazosin lie between 1 and 8 mg per day.
The maximum
recommended dosage is 16 mg per day. The initial dosage is 1 mg, to be
taken before retiring to
bed. This dose is maintained for 1 or 2 weeks. The dose can then be
increased to 2 mg once a day
for another 1 or 2 weeks. If necessary the daily dose can then be
gradually increased, observing
equal intervals, to 4, 8 and 16 mg once a day, depending on the
patient's response.
BENIGN PROSTATE HYPERPLASIA:
The initial dose of doxazosin is 1 mg (1 mg tablet) on the 1st to 8th
day once daily and 2 mg (2
mg tablet) on the 9th to 14th day. Subsequently, dose should be
titrated individually to 4 mg and
to the maximum recommended dosage of 8 mg, depending on the urodynamic
parameters and
the BPH symptomatology of the patient. The recommended titration
interval is 1 to 2 weeks. The
usual recommended dose is 2-4 mg daily. Doxazosin is administered once
a day. If the doxazosin
treatment has been stopped for a number of days, the regimen should be
determined again.
USE IN ELDERLY PATIENTS AND USE IN RENALLY IMPAIRED PATIENTS:
Because
the
pharmacokinetics
of
doxazosin
remain
unchanged
in
patients
with
renal
insufficiency,
and
no
evidence
exists
that
doxazosin
will
exacerbate
an
existing
renal
insufficiency, the application of the usual dosages is ge